CD47 and hepatocellular carcinoma: It was reported that IL-6 secreted by TAMs can upregulate the expression of CD47 in HCC cells through the STAT3 signaling pathway, which in turn affects TAM-mediated phagocytosis, resulting in poor OS and recurrence-free survival (35).